NuGeneris Specialty Pharmaceuticals
Late-phase clinical and commercial manufacturing of therapeutic radiopharmaceuticals
NuGeneris Specialty Pharmaceuticals is a privately held subsidiary of the CPDC specializing in late-phase clinical and commercial manufacturing of therapeutic radiopharmaceuticals for international distribution. Our teams have transferred and developed processes for PET & SPECT imaging agents, alpha and beta radiotherapeutics, small molecules and biologics.
Your process has a lot of moving parts. API synthesis, drug product formulation, fill and finish, product packaging, testing and release all must be carefully orchestrated – even while you’re racing against the clock.
Phone: 905-525-9140, ext. 21212
Contact Email: [email protected]
Are you hoping to connect with this partner? Fill out our form below and we can reach out to you to find the best way to connect you.